Remove Compounding Remove Labelling Remove Magazine
article thumbnail

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals. AI-driven screening methods, such as High-Throughput Screening (HTS), allow researchers to rapidly evaluate large libraries of compounds. Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

For purpose of illustration used throughout this article, labels have been assigned to each CQA. The initial risk assessment is based on information on the target compound as well as prior knowledge and experience from other products with similar characteristics. From there, a preliminary list of CQAs is identified.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

For purpose of illustration used throughout this article, labels have been assigned to each CQA. The initial risk assessment is based on information on the target compound as well as prior knowledge and experience from other products with similar characteristics. From there, a preliminary list of CQAs is identified.

article thumbnail

Vetter breaks ground on $285m US clinical manufacturing site

Pharmaceutical Technology

The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding. How will RFK Jr’s American dream for vaccines play out? Find out more Ground preparation work for the new site commenced in April after obtaining the building permit.

article thumbnail

Pulmonary arterial hypertension market to reach $9.35bn across 7MM by 2034

Pharmaceutical Technology

The pulmonary arterial hypertension (PAH) market is forecast to grow at a compound annual growth rate (CAGR) of 2.0% Symptoms such as fatigue, breathlessness, and chest pain are frequently misattributed to more common conditions, delaying intervention and compounding disease burden. Credit: Green Apple via Shutterstock.

article thumbnail

CTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031

Pharmaceutical Technology

Ross Law July 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The global oncology market is set to grow at a compound annual growth rate (CAGR) of 24.5%. Image credit: CI Photos / Shutterstock. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

article thumbnail

Regulatory Landscape for Raw Materials: CMC Considerations

ISPE

With shortages, regulatory complexity is compounded due to differences in submission and data requirements from various regulatory agencies. Each issue of Pharmaceutical Engineering magazine features thought-provoking content that is available to Members only, but NOW we're giving you exclusive access to see what you've been missing out on.